Solomon R J, Stillman N, Weinberg M S
Adv Exp Med Biol. 1986;198 Pt B:243-51. doi: 10.1007/978-1-4757-0154-8_30.
The hypotensive response the thiazide diuretics was studied in 15 males with moderate essential hypertension and correlated with serial changes in plasma volume, weight, plasma renin activity, urinary aldosterone, and urinary kallikrein, both total and activity. A greater than 10 mmHg fall in mean arterial pressure after four weeks of treatment defined the responders to therapy (n = 10) while all others were considered non-responders (n = 5). In responders, the fall in mean arterial pressure was accompanied by sustained reduction in plasma volume and weight. No sustained fall in plasma volume was noted in non-responders. Plasma renin activity and urinary aldosterone excretion increased in responders but not in non-responders. Urinary kallikrein, both total and active, increased in the responders but remained unchanged in the non-responders. The results are consistent with the hypothesis that a sustained reduction in plasma volume is necessary for the maintenance of a hypotensive response to thiazides. Stimulation of the renal kallikrein-kinin system may be necessary to balance the antinatriuretic and pressor effects of the renin-angiotensin-aldosterone system. If unopposed, this system would return plasma volume and blood pressure to pretreatment levels.
在15名中度原发性高血压男性患者中研究了噻嗪类利尿剂的降压反应,并将其与血浆容量、体重、血浆肾素活性、尿醛固酮以及总尿激肽释放酶和活性尿激肽释放酶的系列变化进行关联。治疗四周后平均动脉压下降超过10 mmHg定义为治疗反应者(n = 10),而所有其他患者被视为无反应者(n = 5)。在反应者中,平均动脉压下降伴随着血浆容量和体重的持续降低。在无反应者中未观察到血浆容量的持续下降。反应者的血浆肾素活性和尿醛固酮排泄增加,而无反应者则未增加。反应者的总尿激肽释放酶和活性尿激肽释放酶均增加,而无反应者则保持不变。这些结果与以下假设一致,即血浆容量的持续降低对于维持对噻嗪类药物的降压反应是必要的。刺激肾激肽释放酶-激肽系统可能是平衡肾素-血管紧张素-醛固酮系统的利钠和升压作用所必需的。如果不加以对抗,该系统会使血浆容量和血压恢复到治疗前水平。